P. Steuber
Baylor College of Medicine
4 Papers
83 Citations
P. Steuber is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Acute lymphocytic leukemia & Cytogenetics. The author has an hindex of 4, co-authored 4 publications. Previous affiliations of P. Steuber include Pediatric Oncology Group.
Chat about Author
Papers
The utility of spectral karyotyping in the cytogenetic analysis of newly diagnosed pediatric acute lymphoblastic leukemia.
Xinyan Lu,C. P. Harris,Linda D. Cooley,J. Margolin,P. Steuber,Michael Sheldon,Pulivarthi H. Rao,Ching C. Lau +7 more
TL;DR: The utility of using multicolor spectral karyotyping in combination with G-banding and FISH to augment the precision with which chromosomal aberrations may be identified in tumor cells is demonstrated.
46
•Journal Article
Transitional Pre-B-cell acute lymphoblastic leukemia of childhood is associated with favorable prognostic clinical features and an excellent outcome : a pediatric oncology group study
M. Koehler,Frederick G. Behm,Jonathan J. Shuster,W M Crist,Michael J. Borowitz,A T Look,David R. Head,Andrew J. Carroll,Vita J. Land,P. Steuber,D. J. Pullen +10 more
TL;DR: It is concluded that patients with transitional pre-B ALL have a very favorable prognosis in the context of the therapy used in this study.
33
Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the Pediatric Oncology Group.
Michael J. Borowitz,Michael J. Borowitz,Andrew J. Carroll,Andrew J. Carroll,J J Shuster,J J Shuster,A. T. Look,Frederick G. Behm,D. J. Pullen,D. J. Pullen,Vita J. Land,Vita J. Land,P. Steuber,P. Steuber,William M. Crist +14 more
TL;DR: For more than a decade, the Pediatric Oncology Group (POG) has been engaged in a series of studies of acute lymphocytic leukemia in childhood in which advances in therapeutic approaches have been undertaken in conjunction with biologic studies of the properties of leukemic cells.
13
•Journal Article
Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study.
Michael L. Graham,Jonathan J. Shuster,Barton A. Kamen,Vita J. Land,Michael J. Borowitz,Bruce M. Camitta,David L. Cheo,M P Harrison,Brigid G. Leventhal,D P Pinkel,D. J. Pullen,P. Steuber,V M Whitehead +12 more
TL;DR: It appears that concurrent administration of methotrexate/cytarabine combination is not optimal, and patients whose levels were extremely low had an adverse prognosis.